You are here

  • Home
  • Archive
  • Volume 21, Issue 2
  • Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer

Authors

  1. Address correspondence and reprint requests to Ingirídur Anna Skírnisdóttir, MD, PhD, Department of Gynecology and Obstetrics, University Hospital, Akademiska sjukhuset, SE-751 85 Uppsala, Sweden. E-mail: ingiridur.skirnisdottir{at}kbh.uu.se.

Citation

Skírnisdóttir IA, Sorbe B, Lindborg K, et al
Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer
International Journal of Gynecologic Cancer 2011;21:236-244.

Publication history

  • Received July 13, 2010
  • First published January 1, 2011.
Online issue publication 
January 01, 2011

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2011 by IGCS and ESGO